The TRPV4 gene provides instructions for making a protein that acts as a calcium channel. This channel, which transports positively charged atoms of calcium (calcium ions) across cell membranes, is found in many types of cells and tissues. Studies suggest that the TRPV4 channel plays a role in a number of different functions in the body. These include the development of bones and cartilage, the tough but flexible tissue that makes up much of the skeleton during early development. It is also be involved in maintaining the body's water balance (osmoregulation) and in certain types of sensation, particularly the sensation of pain. The TRPV4 channel may also play a role in the self-destruction of cells (apoptosis). It likely has additional functions that have not been identified.
Health Conditions Related to Genetic Changes
MedlinePlus Genetics provides information about Charcot-Marie-Tooth diseaseMore About This Health Condition
At least 30 mutations in the TRPV4 gene have been identified in people with metatropic dysplasia, a skeletal disorder characterized by short stature (dwarfism) with other skeletal abnormalities. Most of these mutations change single protein building blocks (amino acids) in the TRPV4 calcium channel. However, a few mutations insert or delete pieces of DNA in the TRPV4 gene.
Studies suggest that the TRPV4 gene mutations that cause metatropic dysplasia overactivate the TRPV4 calcium channel. The resulting increase in calcium in cartilage-forming cells (chondrocytes) may disrupt the early development of cartilage and bone. However, it remains unclear why these mutations affect chondrocytes specifically and how changes in TRPV4 channel activity result in the particular skeletal abnormalities associated with metatropic dysplasia.More About This Health Condition
Mutations in the TRPV4 gene cause a variety of other conditions, most of which affect the developing skeleton or the nervous system.
In addition to metatropic dysplasia, skeletal disorders associated with TRPV4 gene mutations include autosomal dominant brachyolmia; spondylometaphyseal dysplasia, Kozlowski type; spondyloepiphyseal dysplasia, Maroteaux type; and parastremmatic dysplasia. These related conditions involve combinations of short stature, abnormal side-to-side and back-to-front curvature of the spine (kyphoscoliosis), and other problems with developing bones.
Mutations in the TRPV4 gene also cause neurological disorders. This spectrum of related conditions includes Charcot-Marie-Tooth disease type 2C, congenital distal spinal muscular atrophy, which is characterized by weakness of muscles in the legs and hips, and scapuloperoneal spinal muscular atrophy, which involves weakness and wasting (atrophy) of muscles in the shoulders and lower legs.
Most of the TRPV4 gene mutations that cause these skeletal and neurological disorders change single amino acids in the TRPV4 calcium channel. These mutations likely result in an overactive channel, although some research suggests that the mutations may have different effects on channel function in different tissues. Certain TRPV4 gene mutations have been found to cause skeletal disorders in some people and neurological disorders in others. Additionally, some TRPV4 gene mutations can cause both skeletal and neurological features in the same individual. Researchers are working to determine how TRPV4 gene mutations can cause this wide variety of signs and symptoms.
Another bone disorder, known as familial digital arthropathy-brachydactyly, has also been associated with mutations in the TRPV4 gene. This condition is characterized by arthritis in the joints of the fingers and toes (arthropathy) and shortened fingers and toes (brachydactyly). The mutations that cause this condition appear to impair the function of the TRPV4 calcium channel, preventing it from transporting calcium ions effectively. It is unclear how a loss of channel function leads to the specific features of this condition.
Common variations (polymorphisms) in the TRPV4 gene have been associated with two additional disorders: hyponatremia, which is a condition of water imbalance that can cause dangerous brain swelling, and chronic obstructive pulmonary disease (COPD), a common lung disease that causes difficulty breathing. It has not been determined how differences in the function of the TRPV4 calcium channel are related to these two conditions.
Because mutations in the TRPV4 gene are associated with such a wide array of conditions, some researchers have proposed referring to all TRPV4-related disorders as TRPV4-associated peripheral neuropathy and bony dysplasias (TRPV4-PNAB) or TRPV4-opathies.
Other Names for This Gene
- osm-9-like TRP channel 4
- OSM9-like transient receptor potential channel 4
- osmosensitive transient receptor potential channel 4
- transient receptor potential cation channel, subfamily V, member 4
- transient receptor potential protein 12
- vanilloid receptor-like channel 2
- vanilloid receptor-related osmotically activated channel
Additional Information & Resources
Tests Listed in the Genetic Testing Registry
Scientific Articles on PubMed
Catalog of Genes and Diseases from OMIM
- BRACHYOLMIA TYPE 3; BCYM3
- PARASTREMMATIC DWARFISM
- NEURONOPATHY, DISTAL HEREDITARY MOTOR, AUTOSOMAL DOMINANT 8; HMND8
- SPONDYLOEPIPHYSEAL DYSPLASIA, MAROTEAUX TYPE
- SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE; SMDK
- SCAPULOPERONEAL SPINAL MUSCULAR ATROPHY; SPSMA
- TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY V, MEMBER 4; TRPV4
- DIGITAL ARTHROPATHY-BRACHYDACTYLY, FAMILIAL; FDAB
- PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; COPD
- BRACHYOLMIA TYPE 2; BCYM2
- Andreucci E, Aftimos S, Alcausin M, Haan E, Hunter W, Kannu P, Kerr B, McGillivray G, McKinlay Gardner RJ, Patricelli MG, Sillence D, Thompson E, Zacharin M, Zankl A, Lamande SR, Savarirayan R. TRPV4 related skeletal dysplasias: a phenotypic spectrum highlighted byclinical, radiographic, and molecular studies in 21 new families. Orphanet J Rare Dis. 2011 Jun 9;6:37. doi: 10.1186/1750-1172-6-37. Citation on PubMed or Free article on PubMed Central
- Auer-Grumbach M, Olschewski A, Papic L, Kremer H, McEntagart ME, Uhrig S, Fischer C, Frohlich E, Balint Z, Tang B, Strohmaier H, Lochmuller H, Schlotter-Weigel B, Senderek J, Krebs A, Dick KJ, Petty R, Longman C, Anderson NE, Padberg GW, Schelhaas HJ, van Ravenswaaij-Arts CM, Pieber TR, Crosby AH, Guelly C. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat Genet. 2010 Feb;42(2):160-4. doi: 10.1038/ng.508. Epub 2009 Dec 27. Citation on PubMed or Free article on PubMed Central
- Biasini F, Portaro S, Mazzeo A, Vita G, Fabrizi GM, Taioli F, Toscano A, Rodolico C. TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature. Neuromuscul Disord. 2016 Apr-May;26(4-5):312-5. doi: 10.1016/j.nmd.2016.02.010. Epub 2016 Feb 23. Citation on PubMed
- Camacho N, Krakow D, Johnykutty S, Katzman PJ, Pepkowitz S, Vriens J, Nilius B, Boyce BF, Cohn DH. Dominant TRPV4 mutations in nonlethal and lethal metatropic dysplasia. Am J Med Genet A. 2010 May;152A(5):1169-77. doi: 10.1002/ajmg.a.33392. Citation on PubMed or Free article on PubMed Central
- Dai J, Kim OH, Cho TJ, Schmidt-Rimpler M, Tonoki H, Takikawa K, Haga N, Miyoshi K, Kitoh H, Yoo WJ, Choi IH, Song HR, Jin DK, Kim HT, Kamasaki H, Bianchi P, Grigelioniene G, Nampoothiri S, Minagawa M, Miyagawa SI, Fukao T, Marcelis C, Jansweijer MC, Hennekam RC, Bedeschi F, Mustonen A, Jiang Q, Ohashi H, Furuichi T, Unger S, Zabel B, Lausch E, Superti-Furga A, Nishimura G, Ikegawa S. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family. J Med Genet. 2010 Oct;47(10):704-9. doi: 10.1136/jmg.2009.075358. Epub 2010 Jun 24. Citation on PubMed
- Deng HX, Klein CJ, Yan J, Shi Y, Wu Y, Fecto F, Yau HJ, Yang Y, Zhai H, Siddique N, Hedley-Whyte ET, Delong R, Martina M, Dyck PJ, Siddique T. Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4. Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27. Citation on PubMed or Free article on PubMed Central
- Garcia-Elias A, Mrkonjic S, Jung C, Pardo-Pastor C, Vicente R, Valverde MA. The TRPV4 channel. Handb Exp Pharmacol. 2014;222:293-319. doi: 10.1007/978-3-642-54215-2_12. Citation on PubMed
- Krakow D, Vriens J, Camacho N, Luong P, Deixler H, Funari TL, Bacino CA, Irons MB, Holm IA, Sadler L, Okenfuss EB, Janssens A, Voets T, Rimoin DL, Lachman RS, Nilius B, Cohn DH. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia. Am J Hum Genet. 2009 Mar;84(3):307-15. doi: 10.1016/j.ajhg.2009.01.021. Epub 2009 Feb 19. Citation on PubMed or Free article on PubMed Central
- Lamande SR, Yuan Y, Gresshoff IL, Rowley L, Belluoccio D, Kaluarachchi K, Little CB, Botzenhart E, Zerres K, Amor DJ, Cole WG, Savarirayan R, McIntyre P, Bateman JF. Mutations in TRPV4 cause an inherited arthropathy of hands and feet. Nat Genet. 2011 Oct 2;43(11):1142-6. doi: 10.1038/ng.945. Citation on PubMed
- McEntagart M. TRPV4 axonal neuropathy spectrum disorder. J Clin Neurosci. 2012 Jul;19(7):927-33. doi: 10.1016/j.jocn.2011.12.003. Epub 2012 May 20. Citation on PubMed
- Nishimura G, Lausch E, Savarirayan R, Shiba M, Spranger J, Zabel B, Ikegawa S, Superti-Furga A, Unger S. TRPV4-associated skeletal dysplasias. Am J Med Genet C Semin Med Genet. 2012 Aug 15;160C(3):190-204. doi: 10.1002/ajmg.c.31335. Epub 2012 Jul 12. Citation on PubMed
- Tian W, Fu Y, Garcia-Elias A, Fernandez-Fernandez JM, Vicente R, Kramer PL, Klein RF, Hitzemann R, Orwoll ES, Wilmot B, McWeeney S, Valverde MA, Cohen DM. A loss-of-function nonsynonymous polymorphism in the osmoregulatory TRPV4 gene is associated with human hyponatremia. Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):14034-9. doi: 10.1073/pnas.0904084106. Epub 2009 Aug 4. Citation on PubMed or Free article on PubMed Central
- Zhu G; ICGN Investigators; Gulsvik A, Bakke P, Ghatta S, Anderson W, Lomas DA, Silverman EK, Pillai SG. Association of TRPV4 gene polymorphisms with chronic obstructive pulmonary disease. Hum Mol Genet. 2009 Jun 1;18(11):2053-62. doi: 10.1093/hmg/ddp111. Epub 2009 Mar 11. Citation on PubMed
- Zimon M, Baets J, Auer-Grumbach M, Berciano J, Garcia A, Lopez-Laso E, Merlini L, Hilton-Jones D, McEntagart M, Crosby AH, Barisic N, Boltshauser E, Shaw CE, Landoure G, Ludlow CL, Gaudet R, Houlden H, Reilly MM, Fischbeck KH, Sumner CJ, Timmerman V, Jordanova A, Jonghe PD. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain. 2010 Jun;133(Pt 6):1798-809. doi: 10.1093/brain/awq109. Epub 2010 May 11. Citation on PubMed or Free article on PubMed Central